Earnings call transcript: ACG posts strong H1 2026 results as ramp-up continues

ACG reported H1 2026 revenue of $90 million and EBITDA of $50 million, implying a 55.6% margin, while operating cash flow reached $30 million during the Gediktepe ramp-up. Management raised five-year average copper-equivalent production guidance to 36,000 tonnes annually from 20,000 tonnes and projected average annual revenue of roughly $450 million, versus about $130 million historically. The company values Gediktepe at $1.2 billion NPV at consensus commodity prices and plans to refinance its $200 million bond by or before its January 2027 call date, although execution risks remain around sulfide and SART plant commissioning.

Analysis

ACG’s equity rerating hinges less on revised life-of-mine economics than on converting a development-stage valuation into a demonstrably self-funded operating profile. The key near-term disconnect is that equity holders are underwriting two simultaneous execution events while bondholders retain refinancing leverage; a successful refinancing at a yield near current secondary-market levels could reduce annual cash interest by roughly $10-12m versus the original coupon and remove the most obvious discount-rate overhang. Conversely, the market is correctly withholding full NAV credit until concentrate shipments, recoveries, and working-capital conversion validate management’s modeled cash flow.

The Turkish-lira cost base provides meaningful operating leverage if USD metals remain firm, but it is not a free hedge: a disorderly lira move can raise imported reagent, equipment and debt-service costs, while local inflation may lag currency depreciation in wages and contractors. The more material hidden risk is timing: 2027 output will be below the longer-run run-rate, creating a potential valuation air pocket when formal annual guidance is issued. The deferred copper-price-linked payment also means higher copper prices do not accrue entirely to equity, an offset omitted by simplistic spot-NAV comparisons.

Over 1-3 months, investor marketing and evidence of steady sulfide ramp-up can improve liquidity and narrow the small-cap mining discount. Over 6-18 months, the thesis becomes binary around plant availability and recovery rates; the proposed SART return should be discounted heavily until commissioning because metallurgy projects frequently suffer throughput and reagent-consumption surprises. ELD and FM are not direct operating substitutes, but they are useful liquid proxies: copper/gold risk appetite could lift ACG’s multiple in a favorable metals tape, while ACG should underperform both sharply if execution disappoints.

Key Decisions for Investors

• Initiate only a starter long ACG position over the next 1-2 months; add after independently verified commercial-scale concentrate shipments and stable recovery/throughput data. Target a 30-50% rerating over 12 months if refinancing and ramp milestones are met; exit if sulfide commissioning slips beyond Q1 2027 or cash burn requires incremental equity.
• Use a long ACG / short ELD pair for investors seeking to isolate project-delivery upside from gold-price beta. Size ACG at no more than half the ELD short notional given materially lower liquidity and single-asset risk; reassess when 2027 guidance reveals the production trough.
• Monitor the ACG bond yield and refinancing terms as the highest-frequency thesis indicator. A refinancing below roughly 10% without restrictive covenants is a buy catalyst; a failed or delayed refinancing into late 2026 is a reduce/exit signal regardless of reported EBITDA.
• Do not underwrite management’s spot-NAV upside until the technical report’s commodity-price deck, sustaining-capex assumptions, concentrate treatment charges, and contingent copper-price payment are reconciled. Treat any equity strength before those disclosures and operational proof as liquidity-driven rather than fundamental.